NEW YORK, NY — As the world enters the second week of October, a month traditionally synonymous with pink ribbons and early detection messaging, a global movement is preparing to shift the spotlight toward a more sobering reality. On October 13, 2026, more than 325 landmarks across 20 countries will illuminate in a distinct tri-color palette of teal, green, and pink. This coordinated display marks National Metastatic Breast Cancer (MBC) Awareness Day, spearheaded by METAvivor Research and Support through its flagship #LightUpMBC campaign.
The initiative aims to address a critical gap in the public consciousness regarding Stage 4 breast cancer—a condition that currently has no cure. While traditional breast cancer awareness often focuses on "winning the battle" and "finishing treatment," the #LightUpMBC campaign highlights the lives of those for whom treatment is permanent and the stakes are life or death. By turning major architectural icons into beacons of awareness, the campaign seeks to transform symbolic gestures into tangible research funding.
Main Facts: A Global Radiance for Research
The #LightUpMBC campaign has grown into one of the most visible advocacy events in the oncology space. This year, the illumination will span all 50 U.S. states and 195 cities globally. Participating landmarks include architectural giants such as One World Trade Center in New York City, the Willis Tower in Chicago, and Philadelphia City Hall. The reach extends far beyond American borders, with the Ness Bridge in Scotland, the Mactan-Cebu Airport in the Philippines, and Niagara Falls participating in the synchronized event.
The choice of colors is intentional and symbolic. While pink represents the traditional breast cancer movement, teal symbolizes healing and spirituality, and green represents the color of spring and the renewal of life—together signifying the hope for a cure and the vitality of those living with the disease.
The centerpiece of the evening is "#LightUpMBC Live," a free virtual broadcast scheduled for 8 p.m. ET / 5 p.m. PT. Hosted by MBC advocate Tami Eagle Bowling and Broadway star Kara Lindsay, the program serves as a bridge between the scientific community, patient advocates, and the general public. Featuring musical performances from Tony Award winners and nominees, the event is designed to raise funds where 100% of net proceeds are funneled directly into Stage 4 research grants. To date, the campaign has raised over $2.7 million, a figure that organizers expect to climb significantly following the 2026 broadcast.
Chronology: From a Single Bridge to a Global Phenomenon
The origins of #LightUpMBC are rooted in a personal story of friendship and loss. The campaign was founded by Laura Inahara in honor of her best friend, Jessica Moore, who was diagnosed with metastatic breast cancer at the age of 32 and passed away just four years later.
2017: The First Light
The movement began modestly in 2017 with the illumination of a single structure: the Memorial Bridge in Portsmouth, New Hampshire. Jessica Moore’s simple wish was to see a local landmark lit up to recognize the unique struggle of MBC patients.
2018–2021: National Expansion
Following the success of the initial lighting, the campaign gained momentum through social media and grassroots advocacy. METAvivor, a non-profit dedicated exclusively to MBC research, adopted the initiative as its primary awareness vehicle. By 2020, despite the global pandemic, the campaign pivoted to a virtual format with "#LightUpMBC Live," allowing the message to reach a global audience.
2022–2025: International Adoption
The campaign crossed international borders, securing participation from landmarks in the United Kingdom, Canada, and Southeast Asia. The fundraising mechanism became more sophisticated, integrating peer-to-peer giving and corporate sponsorships.
2026: The Present Day
Today, the campaign is a massive logistical undertaking involving hundreds of city councils, building managers, and thousands of volunteers. It has evolved from a memorial for one woman into a global advocacy platform that influences how the public perceives breast cancer.
Supporting Data: The Reality of Metastatic Disease
The urgency of the #LightUpMBC campaign is underscored by stark epidemiological data. Metastatic breast cancer occurs when cancer cells break away from the original tumor in the breast and travel through the bloodstream or lymphatic system to form new tumors in distant organs—most commonly the bones, liver, lungs, or brain.
Mortality and Incidence
According to 2026 projections from the National Cancer Institute’s SEER program, approximately 42,670 people in the United States are expected to die from breast cancer this year. This equates to roughly 117 deaths every single day. Crucially, nearly all of these deaths are the result of metastatic disease. While early detection can improve outcomes, it is not a guarantee; many patients are diagnosed at Stage 4 from the beginning (de novo), while others may see a recurrence years or even decades after being told they were "cancer-free."
The Funding Discrepancy
One of the primary drivers behind METAvivor’s mission is the historical lack of research funding specifically for Stage 4. Historically, only a small fraction of overall breast cancer research funding—estimated by some advocacy groups to be as low as 7-10%—has been dedicated to researching metastatic disease. Most funding has traditionally been directed toward prevention, early detection, and primary treatment.
METAvivor challenges this model by ensuring that 100% of the funds raised through #LightUpMBC go toward grants for MBC research. Their peer-review process is unique because it includes both scientific experts and patient advocates, ensuring that the research funded has the highest potential for immediate patient impact.
Official Responses: Voices from the Front Lines
The leadership of METAvivor and the creators of the campaign emphasize that while the lights are beautiful, the underlying mission is survival.
Dr. Kelly Shanahan, a physician and the Board President of METAvivor, provides a dual perspective as both a medical professional and a patient. "When I was diagnosed with metastatic breast cancer in 2013, I certainly didn’t think I’d still be here 13 years later," Dr. Shanahan stated. "My hope and the hope of so many others lies in research, and METAvivor-funded research is increasingly important these days. #LightUpMBC is the biggest contributor to this research, and is also a way to bring us together as a community."
Laura Inahara, the campaign’s founder, reflects on the legacy of the woman who started it all. "Jessica Moore hoped to illuminate one local landmark. Today, her legacy helps families around the world shine a light for the people they love," Inahara said. She noted that the campaign serves a dual purpose: "It teaches patients with MBC how to advocate for themselves and has now raised over $2.7 million for critical MBC research."
Tami Eagle Bowling, the campaign director and a long-term survivor living with MBC for 11 years, highlights the importance of the live broadcast. "The program features patient stories shared live from illuminated landmarks. We are bringing the scientific perspectives directly to the viewers, making the complex world of oncology research accessible to everyone," Bowling explained.
Implications: Shifting the Narrative of Breast Cancer
The #LightUpMBC campaign represents a significant shift in the "Pink Ribbon" culture. For decades, breast cancer awareness has been characterized by "survivorship" narratives that often alienate those with terminal diagnoses. By carving out a specific day and a specific visual identity, METAvivor is reclaiming space for the metastatic community.
Changing Public Perception
The campaign forces a public conversation about the limitations of current medical technology. It challenges the "early detection saves lives" mantra by highlighting that early detection does not prevent metastasis for everyone. This shift is crucial for fostering a more inclusive and realistic understanding of the disease, which in turn drives political and social pressure for more targeted research funding.
The "Chronic Disease" Goal
The ultimate implication of this research-centric approach is the transformation of MBC from a terminal illness into a manageable chronic condition. As genomic sequencing and targeted therapies evolve, some patients are living longer with a high quality of life. The funds raised by #LightUpMBC are directed toward therapies that can overcome drug resistance, which is the primary cause of death in MBC patients.
Community and Advocacy
Beyond the science, the campaign provides a vital psychological boost to a community that often feels invisible during October. The sight of the One World Trade Center or the Willis Tower glowing in MBC colors provides a sense of validation and global solidarity. It empowers patients to move from passive recipients of care to active participants in the funding and direction of the research that may one day save their lives.
As October 13 approaches, the #LightUpMBC movement stands as a testament to the power of grassroots advocacy. It serves as a reminder that while awareness is the first step, it is the pursuit of scientific breakthroughs that will ultimately change the statistics and offer a future to the 117 people who would otherwise be lost to the disease every day.
How to Participate:
The public is encouraged to visit www.lightupmbc.org to find a map of participating landmarks. Supporters can share photos of the illuminated sites on social media using the hashtags #LightUpMBC and #METAvivor. The live broadcast will be available on METAvivor’s YouTube and Facebook pages, as well as via the LiveOne streaming platform.
About the Author
